New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 12, 2014
07:41 EDTRDUSRadius Health reports Q2 EPS ($2.22), may not compare to consensus (89c)
The net loss per share calculation for the three months ended June 30 includes the weighted average impact of Radius' convertible preferred stock converting into common stock upon the completion of its initial public offering in June. The decrease in net loss for the 2014 period was primarily due to a decrease in research and development expenses.
News For RDUS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 27, 2015
17:31 EDTRDUSRadius Health hires Dr. Lorraine Fitzpatrick as Chief Medical Officer
Radius Health (RDUS) announced that it has hired Dr. Lorraine A. Fitzpatrick as Chief Medical Officer of the Company. Dr. Fitzpatrick was previously Medicine Development Leader of an international clinical development team for Denosumab at GlaxoSmithKline (GSK), responsible for clinical development, regulatory, manufacturing, commercial, operations, epidemiology, and global health outcomes. Previously, Dr. Fitzpatrick led the clinical development of novel agents to treat musculoskeletal diseases and women's health at GlaxoSmithKline. Before joining GlaxoSmithKline, Dr. Fitzpatrick was Executive Director at Amgen, Inc. where she worked in the fields of osteoporosis and oncology.
July 23, 2015
06:04 EDTRDUSRadius Health 4.1M share Secondary priced at $74.00
Subscribe for More Information
July 22, 2015
09:07 EDTRDUSOn The Fly: Pre-market Movers
Subscribe for More Information
07:59 EDTRDUSRadius Health breakthrough therapy request for abaloparatide-SC denied by FDA
Subscribe for More Information
July 21, 2015
19:00 EDTRDUSOn The Fly: After Hours Movers
Subscribe for More Information
16:04 EDTRDUSRadius Health files to sell $250M in common stock
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use